We found that in patients with glioma, B7‐H3, LAG3 and TIM3 were significantly raised, while the expression of PD‐L1, BTLA, TIGIT, PD‐1 and CTLA4 did not seem to be significantly different from those of normal individuals (Figure 4B). This evidence concerns the gene CD276 and central nervous system cancer.